A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALS

Clinical trial NCT02463825 · UNKNOWN

Trial details

NCT number: NCT02463825
Sponsor: University of Calgary
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2015-04-01
Primary completion: 2016-08-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.